The stunning success of CAR T therapy over the past couple years has spawned a new industry and a proliferation of CAR, TCR and TIL constructs. Engineering efforts are aimed at improving the design, targeting, developability, manufacturing, and scalability of new formats to solve issues that remain, including improving the safety of immunotherapy, affordability and targeting of solid tumors. The tumor microenvironment and the microbiome are being tapped to predict the efficacy of immunotherapy and optimize results.

 

Coverage will include, but is not limited to:

 

  • Developing T-cell therapies against emerging indications including autoimmune disorders
  • Proliferating allogeneic therapy in hematological and solid tumors
  • Applying gene editing and CRISPR to immunotherapy design
  • Interrogating and targeting key players in the tumor microenvironment
  • Evaluating how the microbiome can be used to predict immunotherapy success
  • Optimizing manufacturability and scale-up
  • Striking a balance between toxicity and efficacy
  • Selecting combinations of immunotherapies
  • Reviewing recent successes and failures in adoptive T cell therapy
  • Overcoming resistance to therapy with novel strategies

If you would like to submit a proposal to give a presentation at this meeting, please CLICK HERE.

 

The deadline for priority consideration is 26 April 2019.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Christina Lingham

Executive Director, Conferences and Fellow

Cambridge Healthtech Institute

Phone: (+1) 781. 972.5464
Email: clingham@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Jason Gerardi
Senior Manager, Business Development

Cambridge Healthtech Institute
Phone: (+1) 781.972.5452
Email: jgerardi@healthtech.com

 

Companies L-Z
Ashley Parsons
Manager, Business Development

Cambridge Healthtech Institute
Phone: (+1) 781.972.1340
Email: ashleyparsons@healthtech.com